EDGAR Filing Documents for 0001214659-23-016112

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]

SEC Accession No. 0001214659-23-016112

Filing Date

2023-12-06

Accepted

2023-12-06 17:15:42

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDMENT NO. 2	b125232f1a2.htm	F-1/A	1279608
2	EXHIBIT 1.1	ex1_1.htm	EX-1.1	251076
3	EXHIBIT 4.17	ex4_17.htm	EX-4.17	121528
4	EXHIBIT 4.18	ex4_18.htm	EX-4.18	113701
5	EXHIBIT 4.19	ex4_19.htm	EX-4.19	121398
6	EXHIBIT 5.1	ex5_1.htm	EX-5.1	79393
7	EXHIBIT 5.2	ex5_2.htm	EX-5.2	16572
8	EXHIBIT 23.1	ex23_1.htm	EX-23.1	6512
9	GRAPHIC	biodexa_logo.jpg	GRAPHIC	13595
10	GRAPHIC	pipeline1.jpg	GRAPHIC	34967
11	GRAPHIC	pipeline2.jpg	GRAPHIC	18978
12	GRAPHIC	mazars_logomed.jpg	GRAPHIC	10264
	Complete submission text file	0001214659-23-016112.txt		2098588

Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ

Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300

Biodexa Pharmaceuticals Plc (Filer) CIK: 0001643918 (see all company filings)